Aviance Capital Partners’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $3.13M | Buy |
45,369
+33,798
| +292% | +$2.33M | 0.41% | 55 |
|
2025
Q1 | $803K | Hold |
11,571
| – | – | 0.11% | 167 |
|
2024
Q4 | $995K | Sell |
11,571
-5,520
| -32% | -$475K | 0.14% | 146 |
|
2024
Q3 | $2.04M | Buy |
17,091
+770
| +5% | +$91.7K | 0.27% | 93 |
|
2024
Q2 | $2.33M | Buy |
16,321
+98
| +0.6% | +$14K | 0.33% | 75 |
|
2024
Q1 | $2.08M | Buy |
16,223
+1,017
| +7% | +$131K | 0.31% | 80 |
|
2023
Q4 | $1.57M | Buy |
15,206
+5,000
| +49% | +$517K | 0.34% | 69 |
|
2023
Q3 | $928K | Sell |
10,206
-4,000
| -28% | -$364K | 0.21% | 125 |
|
2023
Q2 | $1.15M | Hold |
14,206
| – | – | 0.24% | 119 |
|
2023
Q1 | $1.13M | Sell |
14,206
-2,000
| -12% | -$159K | 0.25% | 111 |
|
2022
Q4 | $1.1M | Buy |
16,206
+8,000
| +97% | +$541K | 0.26% | 111 |
|
2022
Q3 | $409K | Hold |
8,206
| – | – | 0.1% | 183 |
|
2022
Q2 | $457K | Hold |
8,206
| – | – | 0.1% | 185 |
|
2022
Q1 | $456K | Hold |
8,206
| – | – | 0.08% | 190 |
|
2021
Q4 | $460K | Hold |
8,206
| – | – | 0.08% | 196 |
|
2021
Q3 | $394K | Hold |
8,206
| – | – | 0.07% | 207 |
|
2021
Q2 | $344K | Buy |
8,206
+1,124
| +16% | +$47.1K | 0.06% | 211 |
|
2021
Q1 | $239K | Hold |
7,082
| – | – | 0.05% | 246 |
|
2020
Q4 | $247K | Hold |
7,082
| – | – | 0.05% | 236 |
|
2020
Q3 | $246K | Hold |
7,082
| – | – | 0.06% | 225 |
|
2020
Q2 | $232K | Hold |
7,082
| – | – | 0.06% | 219 |
|
2020
Q1 | $213K | Hold |
7,082
| – | – | 0.07% | 198 |
|
2019
Q4 | $205K | Buy |
+7,082
| New | +$205K | 0.05% | 217 |
|
2016
Q1 | – | Sell |
-7,000
| Closed | -$203K | – | 210 |
|
2015
Q4 | $203K | Buy |
+7,000
| New | +$203K | 0.07% | 180 |
|